Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

18.86
+1.277.22%
Volume:759.87K
Turnover:14.78M
Market Cap:53.15M
PE:- -
High:20.07
Open:19.39
Low:18.76
Close:17.59
52wk High:105.60
52wk Low:14.59
Shares:2.82M
Float Shares:2.80M
Volume Ratio:1.75
T/O Rate:27.16%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA warns Novo Nordiskover ‘misleading’ Wegovy ad

TIPRANKS
·
25 mins ago

Hims Scraps Wegovy Copycat Strategy, Shares Plunge 26%

Deep News
·
54 mins ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Yesterday

Novo Nordisk Begins DKK 15 Billion Share Buyback, Details Early February Purchases

TIPRANKS
·
Yesterday

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Kroger, Nvidia, Monday.com, and More -- Barrons.com

Dow Jones
·
Yesterday

Novo Nordisk Sues Telehealth Firm Over $49 Weight-Loss Pills

Deep News
·
Yesterday

Novo Nordisk Sues Hims & Hers for Alleged Patent Infringement Over 'Knock-Off' Wegovy, Ozempic

MT Newswires Live
·
Yesterday

3 Things That Can Ease Stock Market Nerves as Crucial Jobs Report Looms -- Barrons.com

Dow Jones
·
Yesterday

Novo Nordisk Shares Surge as Rival Abandons Low-Cost Wegovy Copycat Plan

Deep News
·
Yesterday

Bank of America flags a really big risk to bonds - the stock market

Dow Jones
·
Yesterday

Hims & Hers Stock Plunges 15%. Why Losing the Novo Wegovy Battle Is a Blow. -- Barrons.com

Dow Jones
·
Yesterday

Barclays Remains a Hold on Novo Nordisk (0QIU)

TIPRANKS
·
Yesterday

HIMS Stock Drops, NVO Jumps after Hims & Hers Halts Selling $49 Wegovy Copy

TIPRANKS
·
Yesterday

Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor

Dow Jones
·
Yesterday

Novo Nordisk Faces Price War in Competitive Anti-Obesity Drug Market with No Relief in Sight

Deep News
·
Yesterday

Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio?

Benzinga
·
Feb 08

Hims & Hers to Stop Offering Wegovy Copycat Drug After Regulatory Scrutiny -- Barrons.com

Dow Jones
·
Feb 08

The Weight-Loss Price Wars Are Breaking Big Pharma's Business Model -- Heard on the Street -- WSJ

Dow Jones
·
Feb 07

Review -- Barron's

Dow Jones
·
Feb 07

Health Regulators Ask DOJ to Investigate Hims & Hers. The Stock Plunges. -- Barrons.com

Dow Jones
·
Feb 07